Summary
With the increasing the use of biomarkers in cancer treatment, the emphasis on selecting the right treatment for the right patient takes on added significance in early drug development. This article discusses the difficulties inherent in selecting patients for early drug-development studies.
- Affordability of Care
- Oncology Clinical Trials
- Molecular Imaging
- Oncology Genomics
- Reproductive Cancers
- Gastrointestinal Cancers
- © 2012 MD Conference Express®
Tools
A Paradigm Shift in Early Drug Development: Individualizing to More Patient Benefit
Permalink:
Table of contents
Cited By...
- No citing articles found.